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IntroductIon
An emerging theme in macrophage biology is that each tis-
sue macrophage is adapted to its local environment and pro-
vides homeostatic support (Amit et al., 2016). Although all 
the tissue macrophages share core gene transcripts, including 
the transcription factor Spi1 (PU.1) and cell surface receptors 
such as Mertk (Mer) and Fcgr1 (CD64), a comparison of dif-
ferent organs reveals substantial differences that may relate to 
a specific function (Gautier et al., 2012). Macrophages share 
a common set of enhancers, but these are differentially ex-
pressed in a tissue-specific manner, leading to their specializa-
tion (Kaikkonen et al., 2013; Lavin et al., 2014). For example, 
red pulp macrophages are specialized to dispose of effete red 
blood cells by sensing heme and inducing Spic (Haldar et al., 
2014). Understanding how the phenotypic qualities of many 
tissue macrophages originate and are influenced by their sur-
rounding tissues is a work in progress.
The pancreas contains distinct resident macrophages in 
the exocrine and endocrine regions (Calderon et al., 2015). 
In each anatomical site, the macrophages differ in their em-
bryonal origin and in their activation status. In an analysis 
performed in C57BL/6 mice, the interacinar macrophages 
were found to express genes and cell surface markers that 
categorize them as M2-like (anti-inflammatory) and tissue 
supportive. In contrast, the macrophages in the islets of Lang-
erhans expressed M1-like transcripts typically associated with 
inflammatory macrophages. The islet macrophage has a ho-
meostatic role, as shown in the op/op mouse, which lacks 
functional CSF-1 protein. In these mice, the islets lack mac-
rophages and develop poorly (Banaei-Bouchareb et al., 2004; 
Calderon et al., 2008, 2015). Also, the islet macrophages are in-
timately associated with intra-islet vessels and in close contact 
with β cells (Calderon et al., 2011). Islet macrophages take up 
dense core granules and can present the contents of the islet 
granule to islet reactive CD4+ T cells (Vomund et al., 2015).
There has been confusion in the field about the identity 
of tissue-resident macrophages and DCs. The main reason has 
been the long-standing assumption that expression of CD11c 
and high MHC-II were specific markers of DCs and that 
high F4/80 was a signature of the macrophage. In fact, CD11c 
and MHC-II expression are not definitive markers, many tis-
sue-resident macrophages express CD11c and MHC-II, and 
F4/80 levels vary across the macrophage lineage. Recent data 
have identified more faithful markers for both cells. In the 
case of macrophages, the cell surface receptors MerTK and 
FcγRI are among the most reliable markers (Gautier et al., 
2012). In the case of DCs, the conventional DCs are best 
defined by a group of genes that includes Zbtb46 and Flt3, 
while the plasmacytoid DC (pDC) lineage is best defined by 
expression of B220, PDCA, and SiglecH (Miller et al., 2012). 
The islet macrophages are positive for expression of canonical 
macrophage proteins or genes such as MerTK, FcγRI, and 
Sfpi1 but do not express the DC markers Zbtb46, Flt3, B220, 
and Siglec H (Ferris et al., 2014; Calderon et al., 2015).
Comparing the islet macrophages from nondiabetic 
mice with early prediabetic mice is important. The macro-
We examined the transcriptional profiles of macrophages that reside in the islets of Langerhans of 3-wk-old non-obese dia-
betic (nod), nod.rag1−/−, and B6.g7 mice. Islet macrophages expressed an activation signature with high expression of tnf, 
Il1b, and MHc-II at both the transcript and protein levels. these features are common with barrier macrophages of the lung 
and gastrointestinal tract. Moreover, injection of lipopolysaccharide induced rapid inflammatory gene expression, indicating 
that blood stimulants are accessible to the macrophages and that these macrophages can sense them. In nod mice, the auto-
immune process imparted an increased inflammatory signature, including elevated expression of chemokines and chemokine 
receptors and an oxidative response. the elevated inflammatory signature indicates that the autoimmune program was active 
at the time of weaning. thus, the macrophages of the islets of Langerhans are poised to mount an immune response even at 
steady state, while the presence of the adaptive immune system elevates their activation state.
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phages constitute the majority of the leukocytes found in is-
lets at steady state, and they can act as a potential modulator 
of T cell activation in vivo. Our studies therefore focus on the 
3-wk-old mouse, a time before there is overt lymphocytic 
infiltration of islets. Overall, the role of the macrophage in 
the autoimmune diabetic process is not well understood. In 
the non-obese diabetic (NOD) mouse, a strain that develops 
spontaneous diabetes, the first inflammatory transcriptional 
signatures that can be detected can be mapped back to my-
eloid cells generally and macrophages specifically (Carrero et 
al., 2013). At this early stage in NOD diabetogenesis, a sec-
ond myeloid cell, the Batf3-dependent XCR1+ DC, enters 
the islets, but the relationship between the two cells is not 
known. The importance of myeloid cells in diabetogenesis is 
reinforced by the finding that the NOD.Batf3−/− mice lack-
ing XCR1+ DCs never develop diabetes (Ferris et al., 2014).
Islet macrophages from two strains of nondiabetic mice 
were in an activated state comparable with other barrier 
macrophages, such as those found within the lung and the 
intestine. They expressed high MHC-II, TNF, and IL-1β, all 
at the transcript and protein level, as well as a host of other 
inflammatory mediators and sensors. Importantly, the islet 
macrophages are sampling blood contents, as there was in-
creased expression of inflammatory transcripts after treatment 
with intravenous LPS. In the NOD mouse, the islet macro-
phage was sensitive to the presence of an adaptive immune 
system, having an increased expression of inflammatory tran-
scripts. Interferon-inducible gene signatures were identified 
in macrophages from 3-wk-old NOD mice, clearly indi-
cating that the diabetic process was already under way very 
early in the life of the mouse. Finally, in a deeper analysis of 
the islet macrophages, a quarter of the NOD macrophages 
had increased inflammatory transcripts, higher than those 
found in the basal state.
resuLts
core features of the nod, nod.rag1−/−, and B6.g7 
islet-resident macrophages
We isolated 3-wk-old islet macrophages (CD45+F4/80+M-
HC-II+) using the gating strategy shown in Fig. S1 A. Note 
that 85–95% of the CD45+ cells in the islets of the 3-wk-old 
NOD mice are macrophages; the remaining cells are mostly 
CD3ε+ T cells (see also Melli et al., 2009). (Previous work 
showed that islets at 3 wk or earlier contained B cells, neutro-
phils, and pDCs [Diana et al., 2013; Diana and Lehuen, 2014]. 
However, our experimental analysis did not reproduce these 
findings [Figs. S2 and S3].)
We compared macrophages isolated from NOD, NOD.
Rag1−/−, and B6.g7 mice pancreatic islets for their gene ex-
pression profiles by RNA sequencing (RNASeq) and cell 
surface marker expression. Examination of the NOD.Rag1−/− 
and B6.g7 mice established their basal features independent of 
autoimmune inflammation. All mice used in this study were 
housed in an advanced pathogen-free barrier facility, devel-
oped normally, and did not have any indication of infections.
We also included lung macrophages and pancreatic LN 
(PLN) XCR1+ DCs (CD45+CD11c+MHC-II+CD172aneg 
CD11bnegXCR1+) for additional comparisons (Fig. S1, B 
and C). A preliminary analysis of the islet macrophage data 
using the Immunological Genome Project (ImmGen) My 
GeneSet tool showed that the lung and intestinal macro-
phages most closely resembled those of the islet (Heng et 
al., 2008). We chose the lung macrophage to determine both 
common and unique gene expression signatures of the islet 
macrophage when compared with other tissue macrophages. 
(There are two annotated lung macrophages in ImmGen: 
the “lung CD11b+ macrophage” that is CD11bhiCD11c+M-
HC-II+CD103negCD24neg and the “lung macrophage” that 
is CD11c+MHC-IInegCD11bnegCD103negSiglecF+. Our pre-
liminary analysis showed high similarity between the islet 
macrophage and the “lung CD11b+ macrophage,” leading us 
to examine that population.) The XCR1+ DCs represent a 
different phagocyte lineage that is highly relevant for the ini-
tiation of diabetes (Ferris et al., 2014). The absence/paucity 
of these DCs in islets at the 3-wk window made it diffi-
cult to analyze them, so instead we isolated them from the 
PLN on the basis of their expression of XCR1. This com-
bination of tissues and cell types allowed us to interrogate 
several questions about the transcriptional profile and biology 
of the islet macrophage.
The top expressed transcripts in 3-wk-old islet mac-
rophages showed similar values (Fig. 1, A–C). Housekeeping 
genes, such as transcriptional regulators and cell structural 
genes (i.e., Actb, Fosb, and Hspa5), were comparably ex-
pressed (Fig.  1  A and Table S1). Most canonical myeloid 
genes were comparably transcribed in both islet macrophages 
and in PLN DCs (Fig. 1 B; Gautier et al., 2012). Included 
in this group were the MHC-II antigen presentation genes 
H2-Aa, H2-Ab1, H2-Eb1, and Cd74. The islet macrophages 
do not initially express uniformly high MHC-II on their sur-
face (Calderon et al., 2015). At 2 wk of age, they have vary-
ing levels of MHC-II on their surface. However, by 4 wk 
of age, MHC-II expression becomes uniformly high (Fig. S1 
D). Unlike DCs, high expression of MHC-II genes is not a 
basal condition in all tissue-resident macrophages. Microglia, 
the large peritoneal macrophages, and alveolar macrophages 
express low levels of MHC-II genes and the master regulator 
Ciita (Fig. S1 E shows data from ImmGen).
Three additional classes of genes integral to the initia-
tion of an adaptive immune response were expressed highly 
in islet macrophages: (1) costimulatory molecules, (2) pat-
tern recognition molecules (TLRs), and (3) chemokines 
(Fig.  1, D–G). (1) The most notable costimulatory genes 
were the activating ligands Cd86 and Pvr (CD155) and the 
inhibitory ligands Lgals9 (Galectin-9) and Cd274 (PD-L1; 
Fig. 1 D). (2) Most TLR genes and adaptor proteins were 
expressed at high levels, including Tlr1, Tlr2, Tlr3, Tlr4, 
Tlr6, Tlr7, Tlr8, Tlr9, Tlr12, and Tlr13, allowing the islet 
macrophages to sense different microbial patterns (Fig. 1 E; 
Kawai and Akira, 2011; Oldenburg et al., 2012; Koblansky 
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Figure 1. transcriptional profiling of islet-resident macrophages. Top expressed housekeeping (A) and myeloid (B) genes from NOD, NOD.Rag1−/−, and 
B6.g7 islet macrophages and DCs. Macrophages and DCs were isolated as indicated in Fig. S1. (C) Core macrophage-specific gene signature (as defined by 
Gautier et al., 2012), distinguishing macrophages from DCs. Expression of costimulatory genes (D), genes encoding TLRs and adaptors (E), chemokines (F), 
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et al., 2013). In contrast, the XCR1+ DCs had reduced or 
absent expression of most of the TLRs, except Tlr3, Tlr9, 
and Tlr11. (3) Chemokine expression consisted of genes 
capable of attracting myeloid cells (Ccl3, Cxcl14), macro-
phages (Ccl9, Cxcl14), neutrophils (Cxcl1, Cxcl2), NK cells 
(Ccl3), NKT cells (Cxcl16), T cells (Ccl4, Cxcl9, Cxcl10, 
Cxcl16) and regulatory T cells (Cxcl9; Fig. 1 F; Matloubian 
et al., 2000; Kurth et al., 2001; Dufour et al., 2002; Zhao et 
al., 2003; Castellino et al., 2006; Yamada et al., 2012; Griffith 
et al., 2014). Finally, islet macrophages expressed chemo-
kine receptors found in inflammatory leukocytes (Ccr2, 
Ccr5), developing leukocytes (Cxcr4), barrier macrophages 
(Ccr2, Ccr5, Ccrl2, Cx3cr1, Cxcr4), and microglia (Cx3cr1) 
but whose combined pattern of expression most resem-
bled barrier macrophages (Fig.  1  G; Gautier et al., 2012; 
Griffith et al., 2014).
Several myeloid genes were differentially expressed in 
the islet macrophages compared with the PLN DCs. Among 
these were Atf3, Rasgef1b, and Rgs1 (Fig. 1 B). Atf3 is down-
stream of TLR4 signaling and acts as a negative regulator of 
cytokine transcript expression after LPS treatment (Gilchrist 
et al., 2006). Rasgef1b encodes a guanine-nucleotide ex-
change factor induced by TLR signaling and believed to 
activate Ras-like proteins (Andrade et al., 2010). Rgs1 en-
codes a regulator of G-protein-coupled signaling that an-
tagonizes chemokine receptor signaling (Reif and Cyster, 
2000; Moratz et al., 2004). Genome-wide association studies 
have linked Rgs1 to celiac disease and type 1 diabetes, but 
its exact function in autoimmunity is poorly defined (Smyth 
et al., 2008). All three of these genes (Atf3, Rasgef1b, and 
Rgs1) are also highly expressed in lung and intestinal macro-
phage (Heng et al., 2008).
For validation purposes, we identified several cell sur-
face receptors using the Panther classification system (Mi 
et al., 2013, 2016). In this way, CD44, CD53, CD83, and 
TLR-7 were identified and validated by flow cytome-
try, as shown in Fig. S1 F.
nod islet macrophages expressed higher levels of 
inflammatory transcripts than nod.rag1−/− at 3 wk of age
We compared the gene expression profiles of the NOD, NOD.
Rag1−/−, and B6.g7 islet macrophages, the CD11b+ lung mac-
rophage, and the XCR1+ DC. Principal component analysis 
(PCA), based on the top 5% of gene expression variance, clus-
tered the islet macrophages tightly along the first and second 
components and related them more closely to the CD11b+ 
lung macrophage than to the PLN XCR1+ DCs (Fig. 2 A). 
Pearson correlation and hierarchical clustering reinforced this 
point, demonstrating the similarity between NOD, NOD.
Rag1−/−, and B6.g7 macrophages (Fig. 2, B and C).
The NOD macrophage at 3 wk contained an activation 
signature when compared with the NOD.Rag1−/− macro-
phage. Using DESeq2, we found 542 genes differentially ex-
pressed at twofold counts (adjusted P ≤ 0.05; Fig. 2, D and 
E). Of these, 314 were up-regulated in NOD and 228 were 
up-regulated in NOD.Rag1−/− (Fig. 2 D).
By hypergeometric analysis, the major Gene Ontol-
ogy (GO) pathways enriched in NOD-up-regulated genes 
mapped to signal transduction, cellular biosynthetic pro-
cess, inflammatory response, response to external stimulus, 
and defense response (Fig. 2 F). The top C2 pathways (cu-
rated gene sets) enriched in NOD macrophages mapped 
to KEGG oxidative phosphorylation, KEGG Huntington’s 
disease, Naba matrisome associated, and KEGG cytokine/
cytokine receptor interaction (Fig. 2 F; Kanehisa and Goto, 
2000; Mootha et al., 2003).
We performed gene set enrichment analysis (GSEA) 
using Broad Institute software (Subramanian et al., 2005), 
and this revealed a correlation of the NOD-up-regulated 
genes with the GO MSigDB biological process gene signa-
tures that associate with oxidative phosphorylation, inflam-
mation, cellular response to reactive oxygen species (ROS), 
and cell proliferation (Fig. 2 G; P < 0.002 and false discovery 
rate [FDR] q < 0.05: response to oxidative stress [GO term: 
0006979], behavior [GO term: 0007610], and inflammatory 
response [GO term: 0006954]).
These findings show that the NOD macrophages are 
transcriptionally and metabolically more active than their 
NOD.Rag1−/− counterparts. First, the behavior and inflam-
matory response grouping contained NOD-up-regulated 
genes involved in chemotaxis, including the chemokine re-
ceptors Ccr1 and Ccr7 as well as the chemokines Ccl5, Cxcl2, 
and Cxcl9 (Fig. 2, H and I). Second, the islet macrophages 
displayed an up-regulation of interferon-inducible genes, 
including Cxcl9 and Ccl5, along with early innate immune 
mediators such as Cd40 (Fig. 2, H and I). A majority of these 
genes are associated with pathogen-associated molecular pat-
tern signaling and are discussed in greater detail in a later 
section. Third, the response to oxidative stress signature con-
tained up-regulated genes encoding proteins with an anti-
oxidant role in cells (Fig.  2  J). For example, Sod1 encodes 
superoxide dismutase 1, one of two enzymes responsible for 
converting superoxide radicals to molecular oxygen and hy-
drogen peroxide (Fridovich, 1995). Prdx2 and Prdx5 encode 
peroxiredoxin 2 and peroxiredoxin 5 antioxidant enzymes, 
which reduce hydrogen peroxide and alkyl hydroperoxides 
(Wood et al., 2003). Finally, the oxidative phosphorylation 
gene signature contained genes whose products are com-
ponents of the four major complexes of the mitochondrial 
electron transport chain as well as the ATP synthase complex 
and chemokine receptors (G) by islet macrophages and PLN DCs. Costimulatory gene selection was based on Chen and Flies (2013). TLR and TLR adaptors 
were based on Chevrier et al. (2011). Chemokines and chemokine receptors were based on Griffith et al. (2014). Data are the mean of three or four samples 
per group and are represented as the log2 global expression level.
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(Fig. 2 K). Combined, these findings point to an increase in 
the oxidative activity of the NOD macrophages compared 
with those of the NOD.Rag1−/− macrophages.
nod macrophages at 3 wk of age already display 
transcriptional signatures of diabetes progression
We examined whether transcripts found during diabe-
tes progression might be up-regulated in the 3-wk-old 
NOD macrophage (Fig. 3 A). We did this by comparing 
the islet macrophage transcriptional signature to our pre-
vious chronological analysis of whole islets in NOD dia-
betes (Carrero et al., 2013). Our previous dataset contains 
the whole-islet transcriptional analysis of type 1 diabetes 
progression in the NOD mouse from 2 wk of age until 
the onset of diabetes (∼20–30 wk). This dataset also in-
cluded control samples from mice that never developed 
diabetes: B6.g7, C57BL/6, and NOD.Rag1−/−. We calcu-
lated Pearson’s correlation of whole-islet transcriptomes 
on the basis of the transcripts differentially up-regulated 
in NOD macrophages (the 314 genes described in Fig. 2, 
D and E; adjusted P ≤ 0.05 and maximum likelihood es-
timate–adjusted fold change ≥2). Those same 314 genes 
were used to calculate Pearson’s correlation between 
whole-islet transcriptomes that ranged between 2 wk 
of age and diabetic onset. We found a gradually increas-
ing and positive correlation from 2 wk to diabetic onset 
(Fig. 3 A and Fig. S4 A).
The up-regulated transcripts parsed into two clusters 
that showed significant enrichment in the MSigDB Ca-
nonical (C2) and GO biological pathways (C5BP) databases 
(Fig. 3 B). Cluster I included genes that are progressively 
up-regulated during NOD diabetes (e.g., Cxcl9, S100a4, 
and Ptgs2). These were enriched by hypergeometric test 
for inflammatory pathways, namely, defense response, im-
mune system process, and cytokine/cytokine receptor in-
teraction (Fig. 3 C and Fig. S4 B). Cluster II, in contrast, 
consisted of genes enriched in developmental pathways, 
such as cellular biosynthetic process, translation, and oxi-
dative phosphorylation. These genes were up-regulated in 
the islets of 2-wk-old mice and recently diabetic NOD 
mice (Fig.  3, B and D; and Fig. S4 C). These transcripts 
indicate increased cellular activity, likely accountable by 
some level of replication.
Inflammatory transcripts in the islet macrophage are the 
hallmark features of a barrier macrophage
GSEA of the genes differentially expressed between NOD 
and NOD.Rag1−/− (Fig.  2  G) revealed a correlation with 
gene signatures identified in cultured bone marrow–derived 
macrophages treated with LPS (dataset: GSE14769 samples, 
unstimulated vs. 40-min LPS bone marrow–derived mac-
rophages dominant-negative (Litvak et al., 2009). Similar 
findings were made interrogating datasets from macrophages 
treated with different inflammatory stimuli. In total, we found 
a significant enrichment score for genes expressed after LPS, 
TNF, and IL-1 treatment of macrophages (Fig. 4 A).
When further compared with ImmGen datasets, the 
macrophages that displayed genes up-regulated in an LPS sig-
nature were all barrier macrophages and exposed to either in-
testinal or airborne stimuli. This association was revealed both 
by hierarchical clustering (Fig. 4 B) and by correlation analy-
sis. Both techniques grouped the intestinal and CD11b+ lung 
macrophages together and showed that barrier macrophages 
as a group had a higher enrichment score for LPS signatures 
than the nonbarrier macrophages (Fig. S4 D).
Gene signatures induced by LPS, TNF, and IL-1 were 
found highest in the CD11b+ lung macrophage, NOD, NOD.
Rag1−/−, and B6.g7 islet macrophages but not in the bone 
marrow macrophage (Fig. 4, C and D). This indicated that at 
steady state, the islet macrophages were in an activated state 
comparable with those at a barrier surface.
The similarities between the islet-resident macrophage 
and barrier macrophages led us to compare our own gene 
expression profiles between the islet and the CD11b+ lung 
macrophage to identify islet macrophage–enriched signatures. 
The top statistically significant canonical signature by GSEA 
that distinguished the islet macrophage from the CD11b+ 
lung macrophage was lysosome (FDR < 1.0E-5, P < 1.0E-
5; Fig.  4, E and F). The lysosome signature included genes 
encoding eight cathepsins (A/B/C/D/H/O/S/Z), Laptm4b, 
Laptm4a (lysosomal protein transmembrane 4 alpha and beta), 
and Lgmn (legumain cysteine protease). This gene signature 
suggested a higher lysosomal activity in the islet macrophages 
than in the CD11b+ lung macrophages (Fig. 4 F; Ewald et 
al., 2011). The lysosomal gene signature was found in all islet 
datasets, indicating that heightened lysosomal function was a 
steady-state feature of islet macrophages.
Figure 2. Analysis of islet macrophage transcriptional diversity. (A) PCA of the 5% of genes with the greatest variability for XCR1+ DCs, NOD CD11b+ 
lung macrophages, and NOD, NOD.Rag1−/−, and B6.g7 islet macrophages. (B) Pearson’s correlation matrix of macrophages and DCs on the basis of all ex-
pressed RNASeq probes. (C) Hierarchical clustering of macrophages and DCs for the top 5% of genes with the greatest variability. (D) Scatterplots of expres-
sion values of all annotated genes. (E) Heat map of differentially expressed genes taken from D. Each dot represents the mean of four independent biological 
replicates for NOD and three for NOD.Rag1−/− conditions. Numbers in plots indicate probes with a DESeq2-calculated fold change between conditions of ≥2 
and adjusted P ≤ 0.05 at an FDR of 5% (red, up-regulated in NOD; blue, up-regulated in NOD.Rag1−/−). (F) GO and canonical (C2) pathway hypergeometric 
analysis of the genes differentially expressed between NOD and NOD.Rag1−/− islet macrophages. (G) Enrichment plots from GSEA analysis performed on 
differentially expressed genes using GO biological process (MSigDB C5BP) signature gene sets. ES, enrichment score. Heat maps of core enrichment genes 
from “inflammatory response” (H), “behavior” (I), “response to oxidative stress” (J), and “oxidative phosphorylation” (K) gene sets, identified by either GO (F) 
or GSEA (G). Heat maps show individual samples and represent the log2 row normalized expression.
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Inflammatory mediator production by the islet macrophages
Intracellular flow cytometry showed production of IL-1β 
and TNF, confirming the RNASeq analysis (Fig. 5 A). About 
half of the NOD.Rag1−/− islet macrophages were producing 
detectable levels of TNF and IL-1β without any stimulation. 
Activation with PMA and ionomycin led to limited increases 
in TNF and IL-1β proteins, revealing that they were at or 
near maximal production (Fig. 5, A and B). For comparison, 
the CD11b+ lung macrophage produced almost no detect-
able TNF but equivalent IL-1β (Fig. 5, A and B). Even when 
pulsed with PMA/ionomycin, CD11b+ lung macrophage 
TNF cytokine production never reached that of steady-state 
islet macrophage levels (Fig. 5 B). Their production of IL-1β 
protein was equivalent to the islet macrophages and did not 
increase when pulsed with PMA/ionomycin (Fig. 5, A and B).
Activation of IL-1β from its pro form to its active form 
requires processing by an active inflammasome-family caspase 
(Dinarello, 2009). Islet macrophages from NOD and NOD.
Rag1−/− expressed a detectable level of active caspase-1 when 
examined with the fluorescent form of the caspase substrate 
YVAD. The CD45-negative fraction (i.e., the endocrine cells) 
was negative (Fig. 6 A).
The data indicate that the islet macrophages are mak-
ing some level of both active IL-1β and TNF. Because both 
receptors converge on the NF-κB pathway, we analyzed our 
transcriptional data, searching for NF-κB family members 
expressed in the whole islet. The only members of the tran-
scription factors and coactivators contained in the NF-κB 
and Rel family detectable above background were Nfkb1 
(p105/p50) and Rela (p65; Carrero et al., 2013). Therefore, 
Figure 3. early inflammatory signature during diabetogenesis. (A) Pearson’s correlation of samples from Carrero et al. (2013) on the basis of genes 
identified using DESeq2 as differentially up-regulated in NOD versus NOD.Rag1−/− macrophages with adjusted P ≤ 0.05 and fold change ≥2. (B) Hierarchi-
cally clustered genes from A in whole-islet transcriptome analysis (top). The Z-score profiles of genes expression in cluster I (red) and cluster II (green) are 
shown (bottom). Sample number ranged from three to six per group. Each column represents data obtained from one biological replicate each composed 
of all the intact islets isolated from one mouse of the indicated genotype. (C and D) Hypergeometric analysis of the genes identified in clusters I and II in B 
using GO biological pathways and C2 canonical pathways.
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Figure 4. Islet macrophages are similar to barrier macrophages. (A) GSEA enrichment plots of NOD versus NOD.Rag1−/− islet macrophage differences 
on the basis of LPS, TNF, and IL-1 signatures. The differences between NOD and NOD.Rag1−/− were compared with published signatures of LPS, TNF, and IL-1 
cells as described in Materials and methods. ES, enrichment score. (B) Hierarchical clustering of ImmGen microarray data for macrophages from different 
tissues. The LPS signature genes were selected for clustering the macrophage microarray data from ImmGen. Heat map shows the log2 row normalized 
expression. (C) LPS, TNF, and IL-1 signatures from bone marrow and lung (CD103negCD11b+) macrophage microarrays (ImmGen), and lung and islet macro-
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we examined the nuclear localization of the NF-κB com-
ponent RelA/p65 (Rütti et al., 2016). Staining for RelA/
p65 revealed a predominantly cytosolic pattern of staining in 
NOD islets at 6 wk of age (Fig. 6 B, top). As a positive con-
trol, islet cells treated with IL-1β induced nuclear localization 
(Fig. 6 B, bottom). Therefore, despite the expression of IL-1β 
and TNF by islet macrophages, there was limited detectable 
nuclear NF-κB in the endocrine pancreas. These data indicate 
that despite the levels of cytokine being made by the islet 
macrophages, the β cells are not strongly signaling.
Islet macrophages respond to blood-borne stimuli
A blood-borne stimulus might be able to induce part of acti-
vation profile in the macrophage, as suggested by the expres-
sion of Tnf, Il1a, and Il1b transcripts. This idea is supported 
by our previous finding that the islet macrophage extended 
filopodia into the lumen of the blood vessel and could inter-
act with blood-borne particles (Calderon et al., 2011).
To determine if a blood-borne TLR-agonist could stim-
ulate the islet macrophage, we injected LPS at low concentra-
tions that would not induce systemic effects. LPS was injected 
intravenously into 3-wk-old NOD and NOD.Rag1−/− mice. 
Islets were isolated 3 h later, and the islet macrophage was 
sorted using the strategy outlined in Fig. S1. Transcripts as-
sociated with signaling of TLR4 were assayed using quanti-
tative RT-PCR (qRT-PCR). The transcripts for Cxcl9, Ccl5, 
Il12b, Nos2, and Il6 were significantly up-regulated after LPS 
injection of NOD.Rag1−/− mice when compared with con-
trol PBS-injected mice (Fig.  6  C). Cxcl9, Ccl5, and Il12b 
were up-regulated in the NOD mice. Notably, the NOD 
mice displayed higher baseline expression than the NOD.
Rag1−/− mice for all markers examined. This was not sur-
prising, as some of these markers were the most differentially 
expressed between NOD and NOD.Rag1−/− mice by RNA-
Seq (Fig. 2 D). In sum, the islet macrophage is accessible and 
reacting to circulating LPS, a strong representative patho-
gen-associated molecular pattern.
single-cell analysis of islet macrophages reveals 
heterogeneity in the nod but not the nod.rag1−/− mice
We examined if the inflammatory gene expression differences 
between NOD and NOD.Rag1−/− islets was due to homoge-
neous or heterogeneous autoimmune activation of the NOD 
macrophages. To interrogate transcriptional heterogeneity at 
the cellular level, we examined individual macrophages from 
NOD and NOD.Rag1−/− islets. Macrophages were sorted 
directly into RNA lysis buffer, cDNA was synthesized and 
preamplified, and qRT-PCR was performed for 95 different 
markers using the Fluidigm Biomark HD system. The starting 
cell inputs were 184 NOD and 95 NOD.Rag1−/− macro-
phages. After outlier detection using Singular analysis soft-
ware, 143 NOD and 79 NOD.Rag1−/− macrophages were 
kept for further analysis.
By PCA, the majority of macrophages from both mice 
clustered together, except for a subset in the NOD samples 
represented by 42 of 184 (22.8%; outlined in Fig. 7 A). The 
combination of ANO VA and fold change analysis was per-
formed on the normalized expression values (log2ex) of the 
single macrophage PCR data (Fig. 7 B). We identified several 
genes previously shown to be differentially expressed between 
NOD and NOD.Rag1−/− samples by RNASeq, including 
Ccl5, Cxcl9, Ly6a, Cd38, and Dnase1l3. However, Cxcl9 was 
the most significant differentially expressed gene. All of the 
cells contained in the NOD outlier population expressed high 
levels of Cxcl9. The population level macrophage RNASeq 
data showed that Cxcl9 was the most differentially expressed 
gene between the NOD and NOD.Rag1−/− samples, and the 
expression of this chemokine was detected only in the NOD 
outlier population (Fig. 2 D and 7 A and Table S1). In total, 26 
of 95 genes interrogated by single cell qRT-PCR were differ-
entially expressed between NOD and NOD.Rag1−/− samples 
at twofold change and P < 0.01. Selection of these genes 
revealed a cluster enriched in only NOD but not NOD.
Rag1−/− samples (Fig. S5 A, left side of the heat map; for the 
heat map of the entire dataset, see Fig. S5 B).
In brief, the islet-resident macrophages in the NOD.
Rag1−/− mouse were homogeneous. In the NOD mouse at 
3 wk, there was heterogeneity in their activation state. There 
was a major set identical to the NOD.Rag1−/− macrophage 
but also a second that expressed the same up-regulated tran-
scripts revealed by the RNASeq analysis.
dIscussIon
We made three key findings that place the resident macro-
phage in a unique position to regulate islet function. First, the 
islet macrophages are in an activated state comparable with 
macrophages exposed at barrier surfaces. This result leads to 
the obvious question: why are these macrophages in such a 
state? The islet is a mini-organ that is constantly responding 
to several stimuli that vary and oscillate, such as blood glucose, 
the most prevalent bioactive molecule. We have reported that 
the macrophages capture dense core granules and therefore 
must be exposed to the products of the β cell (Vomund et al., 
2015). We also showed here how blood products, in our exam-
ple a low dose of LPS, were accessible to the islet macrophage. 
In a previous paper, we indicated that the islet macrophages 
extended filopodia into the blood vessel lumen, which could 
be the interacting structure with the circulation (Calderon et 
phages from the present study. All expressed genes were ranked by expression level, and genes that match to the signatures are depicted as horizontal lines. 
(D) Schematic illustration of expression levels of the LPS, TNF, and IL-1 signatures genes in different macrophages. (E) GSEA enrichment plot of the lysosome 
gene pathway, the top canonical (C2, MSigDB) pathway up-regulated in islet macrophages when compared with CD11b+ lung macrophages. (F) Heat map 
of the core enrichment genes from E. Heat map shows individual samples and represent the log2 row normalized expression.
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al., 2011). In essence, the islet macrophages may be activated 
by intra-islet components as well as by blood products.
A second finding, as mentioned above, is the capacity 
of the islet macrophages to sense blood-borne stimuli. This 
finding opens the question of the biological significance of 
such sensing as well as on the repertoire of stimulants, an issue 
that needs critical evaluation. One needs to keep in mind 
that the Tlr2−/−, Tlr9−/−, and Myd88−/− mice have reduced 
incidences of diabetes (Kim et al., 2007; Wen et al., 2008; Tai 
et al., 2016). It is tempting to postulate that during weaning, 
profound changes occur in the islet macrophage, as was evi-
dent by MHC-II expression. This occurs at a time when the 
islet is subjected to more demands for growth as well as to a 
new intestinal flora. It is possible that the islet macrophage 
senses systemic inflammation, as suggested by the modulation 
of type 1 diabetes by gut flora and systemic infections (Wen et 
al., 2008; Christen and von Herrath, 2011; Markle et al., 2013; 
Yurkovetskiy et al., 2015). We speculate that through this sen-
sory function, the macrophages play a protective role for the 
islets against blood-borne pathogens. Finally, one component 
that may contribute to NOD macrophage activation com-
pared with NOD.Rag1−/− mice is the presence of antibodies, 
particularly those derived from the mother. Evidence in favor 
of this is that the wild-type heterozygote pups born from B 
cell–deficient mice (µMT) display decreased incidence and 
penetrance of diabetes (Greeley et al., 2002).
The third finding is that there are genes characteristic of 
diabetes progression being expressed in 3-wk-old islet mac-
rophages. This implies that even without overt lymphocyte 
infiltration of the islet or destruction of β cells, the adaptive 
immune system is enforcing a degree of activation on the 
islet macrophage. Thus, superimposed on the basal activation 
state, the diabetes susceptible traits impose a further activa-
tion program that is likely to be critical for the development 
and progression of the disease. The single-cell analysis of the 
islet-resident macrophages showed that only a subset of the 
NOD macrophages were more inflamed than those of the 
NOD.Rag1−/−. We cannot conclusively state which signal/
cell type is responsible for the activation of the macrophage 
in a young NOD mouse, but the presence of an interferon 
signature points to an activated diabetogenic T cell acting on 
the islets at these early times. We have found a few T cells 
in islets at this early time period (Carrero et al., 2013). Also, 
up-regulation of the oxidative phosphorylation in NOD 
macrophages, as well as self-defense antioxidant enzyme ex-
pression (response to oxidative stress, GO term 0006979), 
suggests antimicrobial generation of ROS. Higher ROS syn-
thesis in NOD macrophages compared with NOD.Rag1−/− 
Figure 5. Flow cytometric evaluation of 
islet macrophages for transcriptionally 
identified markers. (A) The islets and lungs 
of 3-wk-old NOD and NOD.Rag1−/− mice 
were isolated and single-cell suspensions 
were made. Cells were stained with antibod-
ies against cell surface markers and then fixed 
and stained with antibodies against intracellu-
lar pro-form IL-1β and TNF. Plots were gated 
on CD45+CD11c+MHC-II+CD11b+F4/80+. The 
percentages of cells positive are indicated in 
each quadrant. Results are representative of 
three independent experiments per condition. 
(B) Graphs of the percentage of macrophages 
positive for either TNF or IL-1β as determined 
in A. Bars show the mean ± SD for at least 
three independent experiments per condition.
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might be a result of synergistic action of adaptive and innate 
immune response (T cell and macrophage activation) as op-
posed to only an innate response in NOD.Rag1−/−. During 
diabetogenesis, it is the lymphocytic infiltrate that is most 
likely responsible for the cell division and cellular activity sig-
nature in whole islets. Activated macrophages are known to 
express genes responsible not only for cytokine and chemok-
ine production but also for cell cycle progression and prolif-
eration (Buxadé et al., 2012).
Because NOD macrophage autoimmune activation is 
dependent on the presence of the adaptive immune system, 
it is likely that there is heterogeneity in immune components 
within a single islet or among them, with some affected and 
others not. Resolving this will require isolating single mac-
rophages from individual hand-picked islets, a difficult task 
given current technologies. However, this will be an import-
ant issue to tackle, as it will instruct us as to the nature of the 
activation of the earliest sensors of autoimmune diabetes, the 
Figure 6. Inflammatory status of islets before and after treatment with LPs. (A) NOD or NOD.Rag1−/− mouse islet macrophages were isolated and 
stained with the intracellular caspase-1 substrate FAM FLI CA YVAD-FMK. The black histograms are gated on the CD45-negative fraction of the islets, and 
the gray histograms are gated on macrophages as in Fig. S1. Mean fluorescent intensity (MFI) is indicated on the graphs. MFIs for active caspase-1 ranged 
from 62.5–102 (mean 72.2) for the CD45neg population and from 388–884 (mean 625) for the F4/80+ population. Data are representative of two or three 
independent experiments per group. (B) Islets from 6-wk-old NOD mice were isolated, dispersed, and cultured overnight in chamber slides in the absence 
or presence of IL-1β. Cells were then stained with DAPI (blue) and anti-RelA/p65 (red). Cells were imaged by confocal microscopy. Bar, 4 µm. Image is rep-
resentative of three independent experiments. (C) Expression of inflammatory gene transcripts in macrophages isolated from islets of mice intravenously 
injected with LPS. The indicated mice were treated with either PBS (UT) or LPS IV (LPS). Then, islet macrophages were flow-sorted, RNA was isolated, and 
qRT-PCR was performed on the indicated markers. Each symbol represents one individually sorted sample. Horizontal bars show the mean. Significance was 
tested using the Mann-Whitney U test. *, P < 0.0332; **, P < 0.0021; ***, P < 0.0002. Graphs show all the data from at least three independent experiments 
performed in duplicate for each condition.
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macrophage, as well as the distribution of islet involvement 
in the autoimmune process. Thus, intervention and identifi-
cation of those who will progress to diabetes must be done 
much earlier than diagnosis to intervene and prevent diabetes.
The islet macrophages express IL-1β and TNF at the 
steady state. Expression of IL-1β and TNF (and other cyto-
kines) is a complex process (Aggarwal, 2003; Dinarello, 2009; 
Pasparakis, 2009). It involves several transcriptional regula-
tors that modulate the level and time of expression of the 
gene (Foster et al., 2007; Amit et al., 2009; Yosef and Regev, 
2011, 2016; Kotas and Medzhitov, 2015). This regulation is 
of particular relevance. As noted earlier, Atf3 is expressed by 
the macrophages, indicating a degree of regulation of TLR 
signaling. Regarding IL-1β, we find an intermediate expres-
sion of active caspase-1 but failed to detect RelA by nuclear 
staining in the β cells. However, we may well be missing a 
low level of activation and are guarded in concluding a lack 
of IL-1β signaling in the β cell. Indeed, it is still likely that 
there is a level of homeostatic role for IL-1R signaling in 
endocrine function. For example, the p85α component of 
the PI3 kinase is activated by IL-1R signaling (Reddy et al., 
1997). Deficiency of p85α leads to reduced insulin secretion 
after glucose challenge (Terauchi et al., 1999). Also, IL-1β 
treatment of islets instigates down-regulation of the glu-
cose transporter GLUT2 and glucokinase (Park et al., 1999). 
Finally, IL-1R1-deficient mice develop late-onset obesity 
(García et al., 2006). In sum, IL-1 production by the islet 
macrophage may be one component in its general role as a 
modulator of glucose homeostasis influencing the pancreas, 
fat depots, and central nervous system (del Rey et al., 2006; 
Dror et al., 2017). Concerning its role in the autoimmune 
process, much has been discussed on IL-1’s role in diabetes 
initiation, largely on the basis of the harmful effects of IL-1 
on long-term cultures of β cells (Mandrup-Poulsen et al., 
2010). However, a role in diabetes progression in the NOD 
mouse model is not evident. Genetic ablation of caspase-1 
does not alter diabetes development (Schott et al., 2004). 
IL-1R deficiency delays progression to diabetes, albeit mod-
estly (Thomas et al., 2004). As for TNF, its effects are pleio-
tropic but are also under strict control. TNF can affect not 
only β cells but also the vascular endothelium and T cells. 
In contrast to IL-1β, TNF has complex effects on diabetes 
development, most likely on the effector stage of the dis-
ease by modifying not only β cells but also T cells (Yang 
et al., 1994; Kägi et al., 1999; Pakala et al., 1999; Wu et al., 
2002; Chee et al., 2011).
The data indicate that the islet macrophage is subjected 
to stimuli derived from β cells as well as by blood products 
(Calderon et al., 2011; Vomund et al., 2015). Therefore, this 
leads to a transcriptional program that is complex, represent-
ing the diverse stimuli, and these responses need to be inte-
grated. In the absence of macrophages as in the op/op mouse 
the development of islets is impaired (Banaei-Bouchareb 
et al., 2004). Studies are now under way in our laboratory 
to determine the activation state of islet macrophages de-
rived from different strains and ages of mice and under dif-
ferent biological conditions. The islet macrophages of all 
strains examined contain macrophages with core features 
similar to NOD.Rag1−/−. In contrast, the signature of dia-
betic inflammation that includes Cxcl9 and other interfer-
on-inducible genes has been found only in NOD, not in any 
of the control strains.
MAterIALs And MetHods
Mice
NOD/ShiLtJ (NOD), NOD.129S7(B6)-Rag1tm1Mom/J (NOD.
Rag1−/−), and B6.NOD-(D17Mit21-D17Mit10)/LtJ (B6.g7) 
mice originally obtained from The Jackson Laboratory were 
bred and maintained under specific pathogen-free condi-
tions in our animal facility. All experiments were approved 
by the Division of Comparative Medicine of Washington 
University School of Medicine in St. Louis (Association for 
Assessment and Accreditation of Laboratory Animal Care, ac-
creditation number A3381-01).
Figure 7. single-cell qrt-Pcr of islet macro-
phages reveals nod heterogeneity. (A) PCA of the 
single-cell qRT-PCR results. The samples circled in black 
were all Cxcl9+, whereas no Cxcl9+ cells were found in 
the rest of the samples. PC, principal component. (B) 
Volcano plot of the fold change (FC; log2) expression 
between NOD and NOD.Rag1−/− compared with the 
ANO VA p-value (log10). Genes in the upper right quad-
rant had greater than twofold higher expression on 
average in NOD versus NOD.Rag1−/− and were signifi-
cantly differentially expressed by ANO VA at P < 0.01.
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Antibodies
The following antibodies were purchased from BioLegend: 
FITC/PE/PerCP-Cy5.5 anti-B220 (RA3-6B2), PE-Cy7 an-
ti-CD11b (M1/70), PE/APC-Cy7 anti-CD11c (N418), PE/
APC anti-CD274 (10F.9G2), PE-Cy7 anti-CD4 (RM4-5), 
APC-Cy7 anti-CD44 (IM7), BV510/APC anti-CD45 (30-
F11), FITC anti-CD53 (OX-79), FITC/PerCP-Cy5.5 an-
ti-CD8a (53-6.7), PE-Cy7 anti-CD83 (Michel-19), FITC/
APC anti-F4/80 (BM8), and APC anti-TNF (MP6-XT22). 
The following antibodies were purchased from eBioscience: 
fixable viability dye eflour780 and PerCP efluor710 proIL-1β 
(NJT EN3). The following antibodies were purchased from 
BD: FITC/APC anti-CD3e (145-2C11), PE anti-IFNγ 
(XMG1.2), and PE anti-TLR7 (A94B10). Pacific Blue I-Ag7 
(AG2.42.7) was made in our laboratory (Suri et al., 2002).
Flow cytometry and cell sorting
Islets were harvested as described previously (Calderon et 
al., 2015) and dispersed using Cell Dissociation Solution 
Non-Enzymatic (Sigma-Aldrich) for 5 min at 37°C. PLNs 
and lungs were harvested, finely chopped with scissors, placed 
in DMEM (Thermo Fisher Scientific) containing 125 μg/
ml Liberase TL (Roche) and 50 μg/ml DNase I, grade II 
(Roche), and incubated at 37°C for 30 min and dispersed via 
gentle agitation. Single-cell suspensions incubated in PBS, pH 
7.4 (Thermo Fisher Scientific) having 1% BSA (Sigma-Al-
drich), and 50% of 2.4G2 conditioned DMEM at 4°C for 
15 min to block Fc receptors. Cells were stained with flu-
orescently labeled antibodies and sorted using a FAC SAria 
II or analyzed using the FAC SCanto II (BD). Macrophages 
were sorted on the basis of their expression of CD45, F4/80, 
and I-Ag7. DCs were selected on the basis of their expression 
of XCR1. In all cases CD3e+ and CD19+ events were elim-
inated from the sort (dump gated). For cell sorting exper-
iments, ∼500–5,000 macrophages were isolated from 6–10 
mice, and this represented 1 biological sample in our analysis. 
At least three samples were used for each population studied 
by RNASeq analysis. All flow cytometry data were analyzed 
using FlowJo software version 10.2 (Tree Star).
Intravenous LPs injection
NOD and NOD.Rag1−/− mice were intravenously injected 
with 100 ng LPS in 0.1 ml PBS. Mouse islets were harvested 
3 h later and dispersed, and macrophages were sorted using 
the FAC SAria II (BD) after staining with antibodies to CD45, 
CD3, CD19, F4/80, and I-Ag7.
rnA isolation and real-time Pcr
Sorted cell RNA was isolated using the Ambion RNAque-
ous-Micro kit (Thermo Fisher Scientific) following the 
manufacturer’s instructions. RNA was quantified by OD260 
using NanoDrop (Thermo Fisher Scientific). cDNA was 
synthesized using iScript Reverse Transcription Supermix 
for qRT-PCR (Bio-Rad Laboratories). qRT-PCR was per-
formed using the 5′ nuclease (TaqMan) chemistry using 
iTaq Universal Probes Supermix (Bio-Rad Laboratories). 
The 18S ribosomal RNA probe was obtained from Thermo 
Fisher Scientific, and all other primers and probes were de-
signed and obtained from IDT DNA. All quantitative PCRs 
were performed on a StepOnePlus Real-Time PCR system 
(Thermo Fisher Scientific) running StepOne 2.3 Software 
(Thermo Fisher Scientific). Quality control was performed 
by the StepOne 2.3 software. RT-PCR data analysis was done 
using Excel (Microsoft).
rnAseq analysis
Library preparation was performed with 1–50 ng total RNA; 
integrity was determined using an Agilent Bioanalyzer (Ag-
ilent Technologies). Double-stranded cDNA was prepared 
using the SeqPlex RNA Amplification kit (Sigma-Aldrich) 
per the manufacturer’s protocol. cDNA was blunt ended, had 
an adenosine added to the 3′ ends, and then had Illumina 
sequencing adapters ligated to the ends. Ligated fragments 
were then amplified for 12 cycles using primers incorporat-
ing unique index tags. Fragments were sequenced on an Illu-
mina HiSeq-2500 using single reads extending 50 bases. All 
RNASeq work was performed by the Genome Technology 
Access Center at Washington University School of Medicine.
We assessed the mean quality of sequencing reads for 
base pair positions in each sample using the fastqc utility from 
fastq-tools (Droop, 2016). Samples with a quality score less 
than 25 (Sanger/Illumina 1.9 encoding) across all bases were 
truncated using the fastx_trimmer utility, removing base pairs 
from the end of each read in the library. All libraries were 
aligned to the GRCm38.p4 assembly of the mouse genome 
using the STAR aligner (Dobin et al., 2013) with GEN 
CODE version M7 (Harrow et al., 2012) transcripts included 
into the pregenerated reference. We generated raw counts of 
the number of tags on each gene by using htseq-count utility 
from the HTseq package (Anders et al., 2015). GEN CODE 
version M7 (with -t exon option) was used as a reference 
GTF. The DESeq2 package (version 1.6.3; Love et al., 2014) 
was used to detect differentially expressed genes between the 
analyzed conditions (output with P < 0.05 and a Benjami-
ni-Hochberg FDR of 5% was used). Variance between sam-
ples was stabilized for the purposes of hierarchical clustering 
and PCA to address the problem of heteroscedasticity (de-
pendence of variance on the mean counts). Pathways analysis 
was done using the Broad Institute’s GSEA software (Subra-
manian et al., 2005). All heat maps are in log2 scale.
LPs, tnF, and IL-1 signature analysis
The LPS signature consists of genes up-regulated in macro-
phages treated with LPS for 40 min when compared with 
untreated macrophages at P < 0.05, log fold change >1 
(GSE14769). The IL-1 signature consists of genes up-reg-
ulated in human monocyte-derived macrophages 4  h after 
stimulation with IL-1 compared with control cells (GSE8515, 
P < 0.05, log fold change >0.7). The donor effect for the 
GSE8515 data set was corrected with ComBat (Johnson et 
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al., 2007). The limma package was used for differential ex-
pression analysis of microarray data (Ritchie et al., 2015). The 
TNF signaling gene set was taken from the Broad Institute 
Molecular Signatures Database (MSigDB) hallmark gene sets 
(Hallmark TNF signaling via NF-κB). The ImmGen dataset 
was downloaded from GEO (GSE15907; Heng et al., 2008).
Intracellular flow cytometry
Dispersed islet or PLN cells were placed at 37°C in DMEM, 
10% FBS (GE Healthcare), and 10 μg/ml Brefeldin A for 4 h. 
As a positive control for activation, samples were pulsed with 
100 ng/ml PMA (Sigma-Aldrich) and 500 ng/ml ionomycin 
(Sigma-Aldrich). Cells were washed with PBS, 1% BSA, cell 
surface stained with fluorescent antibodies for 30 min at 4°C, 
and fixed with PBS and 2% formaldehyde (Sigma-Aldrich) 
for 15 min at 4°C. Cells were washed with PBS and 1% BSA, 
incubated with 2% saponin (Sigma-Aldrich) and PBS for 5 
min at 4°C, and then with fluorescent antibodies recognizing 
intracellular proteins for 30 min at 4°C. Cells were washed 
with 2% saponin and PBS and then with PBS and 1% BSA. 
Flow cytometry was performed using a FAC SCanto II.
Immunofluorescence microscopy
For nuclear RelA detection, islets from 6-wk-old NOD fe-
males were isolated and dispersed as described previously. 
Dispersed cells were placed in chamber slides and incubated 
at 37°C overnight in 20 ng/ml IL-1β (PeproTech) DMEM 
(Thermo Fisher Scientific) supplemented with 10% FGE 
(Healthcare Life Sciences) or in DMEM 10% FBS alone 
(Rütti et al., 2016). Cells were washed with 1% BSA in 
PBS and fixed and permeabilized using the BD Fix/Perm 
kit according to the manufacturer’s instructions. Cells were 
stained with NF-κB p65 (D14E12) XP rabbit mAb (Cell 
Signaling Technology) overnight at 4°C. Cells were washed 
twice with PBS and stained with Alexa 488 anti-rabbit IgG 
F(ab')2 (Cell Signaling Technology) for 2 h at room tempera-
ture. After washing with PBS, the chamber was removed, and 
Prolong Gold Anti-Fade Reagent with DAPI (Cell Signaling 
Technology) was applied. Slides were imaged using a Leica 
SPE confocal microscope.
For pancreas immunofluorescence, frozen sections from 
each tissue were cut on a cryotome at 10 μm. Sections were 
fixed for 5 min in ice-cold acetone. Then the sections were 
blocked with Cas-Block (Thermo Fisher Scientific) follow-
ing the manufacturer’s instructions. The sections were then 
stained with PE anti-B220 (RA3-6B2), PE anti-Siglec H 
(551), or PE anti-Ly6G (1A8; eBioscience) and polyclonal 
guinea pig anti-insulin (Thermo Fisher Scientific) for 1 h at 
room temperature. Sections were washed three times with 
PBS and then stained with goat anti–guinea pig Alexa-488 
(A11073; Thermo Fisher Scientific) for 1 h at room tempera-
ture. Background autofluorescence was quenched with 70% 
ethanol supplemented with 0.5% Sudan Black B (Sigma- 
Aldrich) for 2 min at room temperature and washed with PBS. 
Nuclei were stained with bisBenzimide H 33258 (Sigma- 
Aldrich) at a concentration of 1 μg/ml in water for 5 min at 
room temperature and washed three times with PBS. Sections 
were mounted with PBS containing 50% glycerol and visual-
ized via an Olympus BX51 microscope.
Active caspase-1 detection
Islets were isolated and dispersed as described previously. Cells 
were incubated for 30 min at 37°C with the fluorescent inhib-
itor probe FAM-YVAD-FMK (Immunochemistry Technolo-
gies) to label active caspase-1 enzyme. Cells were washed and 
stained for cell surface antigens, acquired using a FAC SCanto 
II flow cytometer, and analyzed using FlowJo software.
single-cell sorting and quantitative Pcr
Islet macrophages were isolated, stained, and single-cell-
sorted into 96-well plates containing 5 μl Cellsdirect 2X 
Reaction Mix (Thermo Fisher Scientific) and 0.1 μl RNase 
inhibitor (SUP ERase-In; Thermo Fisher Scientific) per 
well. For reverse transcription and specific cDNA preampli-
fication, all the 96 20× Taqman assays (Fig. S5; IDT DNA) 
were mixed and diluted to 0.2×. Subsequently, 2.5 μl of 
the 0.2× Taqman assay mix, 0.2 μl of the SuperScript III 
RT/Platinum Taq (Thermo Fisher Scientific), and 1.2 μl 
PCR-certified water (Thermo Fisher Scientific) were added 
together to the sorted single cells. Reverse transcription (15 
min at 50°C) was performed, followed by Taq activation (2 
min at 95°C) and 18 cycles of cDNA preamplification (each 
cycle: 15  s at 95°C, 4 min at 60°C). The resulting cDNA 
product was diluted with PCR-certified water (1:5) and 
submitted for single-cell quantitative PCR using the Bio-
mark HD system (Fluidigm).
data availability
RNAseq data are available at the Gene Expression Omnibus 
under accession no. GSE100067.
online supplemental material
Fig. S1 shows the gating strategy for the isolated cells, ex-
pression of MHC on macrophages from ImmGen, and flow 
cytometry of cell surface markers on islet macrophages. 
Fig. S2 shows immunofluorescence of pancreas and lym-
phoid structures. Fig. S3 shows different islet isolation tech-
niques and outcomes. Fig. S4 shows Pearson correlation, 
heat maps, and gene set enrichment analysis. Fig. S5 shows 
single-cell islet macrophage qRT-PCR data. Table S1, in-
cluded in a separate Excel file, shows the normalized gene 
counts for the dataset.
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Figure S1. Analysis of islet macrophages. (A) Flow cytometry gating strategy for sorting of macrophages from 3-wk-old mice. Cells were gated on the 
basis of forward and side scatter, single cells, CD45 expression, MHC-II, and F4/80 expression. Flow cytometry gating strategy of lung macrophages (B) 
and PLN XCR1+ DC (C) populations. Lung macrophages were gated on FSC/SSC, singlets, live dead, CD45, CD11c, F4/80, and MHC-II expression. XCR1+ DCs 
were gated on FSC/SSC, singlets, CD45, CD11c, MHC-II, CD11b, CD172a, CD103, and XCR1. (D) Expression of I-Ag7 on CD45+ CD11c+ F4/80+ macrophages 
isolated from islets of 2-wk-old and 4-wk-old NOD female mice. (E) Expression of MHC-II complex genes, including the master regulator Ciita by different 
macrophage populations, on the basis of the ImmGen dataset (GSE15907). (F) Flow cytometry of CD45+ CD11c+ I-Ag7+ NOD macrophages examining for 
CD44, CD53, CD83, and TLR7.
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Figure S2. Immunofluorescence of pancreas and lymphoid tissue. (A, C, and E) Pancreatic sections and (B) splenic sections or (D and F) peripancreatic 
lymphoid aggregates (LA) were stained with anti-insulin (β cells) and (A and B) Siglec H (pDCs), (C and D) B220 (B cells), or (E and F) Ly6G (neutrophils). All 
sections were nuclear-stained with bisbenzimide. (G) The indicated number of islets were scored for the presence of either B220+, 1A8 (Ly6G)+, or SiglecH+ 
cells. Results were obtained from NOD mice at 3 wk and C57BL/6 mice at 8 wk of age (three mice for each).
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Figure S3. Imaging of isolated islet preparations. (A and B) C57BL/6J and (C and D) NOD pancreata were digested without hand picking and imaged. 
(E and F) NOD pancreata were digested, hand-picked under a dissection microscope, and imaged. All islet preparations were stained with dithizone to allow 
visual separation of islets from the acinar or lymphoid aggregate structures that associate with pancreas digestion preparations. Arrows indicate contam-
inating acinar or leukocytic aggregate structures.
S23JEM 
Figure S4. There are two clusters of genes up-regulated in islet NOD macrophages compared with islet NOD.Rag1−/− macrophages. (A) Pear-
son’s correlation between all samples on the basis of genes, differentially up-regulated in NOD versus NOD.Rag1−/− islet macrophages with P ≤ 0.05, and 
maximum likelihood estimate–moderated fold change ≥2. Heat maps of (B) cluster I and (C) cluster II genes. (D) GSEA plots of lamina propria, serosal, and 
CD11b+CD103neg lung macrophages comparing with other macrophages from ImmGen dataset, on the basis of LPS signature. ES, enrichment score.
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Figure S5. Heat map of single islet macrophage qRT-PCR data. Single-cell qRT-PCR data for NOD and NOD.Rag1−/− macrophages were hierarchically 
clustered using Pearson’s correlation. (A) Genes selected as significant in Fig. 7 B and (B) all genes were plotted by hierarchical clustering using Pearson’s 
correlation for grouping and global Z score for scaling. The key on the bottom of the heat map indicates the cell type examined.
Table S1, included in a separate Excel file, is a gene expression table of islet and lung macrophages and NOD PLN DCs.
